- Effect of Statin on the Reference Segments after Bare-Metal Stent Implantation
-
Kim BK, Hong MK
- KMID: 964714
- Korean J Intern Med.
- 2010 Dec;25(4):353-355.
- doi: 10.3904/kjim.2010.25.4.353
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Impact of Generic Clopidogrel Bisulfate on Platelet Inhibition in Patients with Coronary Artery Stents: Results of the ACCEL-GENERIC Study
-
Jeong YH, Koh JS, Kang MK, Ahn YJ, Kim IS, Park Y, Hwang SJ, Kwak CH, Hwang JY
- KMID: 1785672
- Korean J Intern Med.
- 2010 Jun;25(2):154-161.
- doi: 10.3904/kjim.2010.25.2.154
BACKGROUND/AIMS: In patients with coronary artery stents, the cost of clopidogrel has been cited as a factor in the premature discontinuation of therapy. Thus, the introduction of lower-cost generic clopidogrel... -
- CITED
-
- Close
- SHARE
-
- Close
- Determination of the Prevalence of Aspirin and Clopidogrel Resistances in Patients with Coronary Artery Disease by using Various Platelet-function Tests
-
Woo KS, Kim BR, Kim JE, Goh RY, Yu LH, Kim MH, Han JY
- KMID: 1022035
- Korean J Lab Med.
- 2010 Oct;30(5):460-468.
- doi: 10.3343/kjlm.2010.30.5.460
BACKGROUND: Dual therapy with aspirin and clopidogrel has emerged as the gold standard therapy for patients treated with drug-eluting stents (DES). However, there is variability in patients' responses to this... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Outcomes of Complete Versus Incomplete Revascularization for Patients with Multivessel Coronary Artery Disease and Left Ventricular Systolic Dysfunction in Drug-Eluting Stent Era
-
Sohn GH, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Gwon HC, Lee SH
- KMID: 2069931
- J Korean Med Sci.
- 2014 Nov;29(11):1501-1506.
- doi: 10.3346/jkms.2014.29.11.1501
We aimed to investigate that complete revascularization (CR) would be associated with a decreased mortality in patients with multivessel disease (MVD) and reduced left ventricular ejection fraction (LVEF). We enrolled... -
- CITED
-
- Close
- SHARE
-
- Close
- A Prospective, Randomized Comparison of Promus Everolimus-Eluting and TAXUS Liberte Paclitaxel-Eluting Stent Systems in Patients with Coronary Artery Disease Eligible for Percutaneous Coronary Intervention: The PROMISE Study
-
Kim U, Lee CH, Jo JH, Lee HW, Choi YJ, Son JW, Lee SH, Park JS, Shin DG, Kim YJ, Jeong MH, Cho MC, Bae JH, Lee JH, Kang TS, Jung KT, Jung KH, Lee SW, Cho JH, Kim W, Hur SH, Kim KS, Park HS, Kim MH, Hwang JY, Kim DI, Kim TI
- KMID: 1777657
- J Korean Med Sci.
- 2013 Nov;28(11):1609-1614.
- doi: 10.3346/jkms.2013.28.11.1609
We aimed comparing two-year clinical outcomes of the Everolimus-Eluting Promus and Paclitaxel-Eluting TAXUS Liberte stents used in routine clinical practice. Patients with objective evidence of ischemia and coronary artery disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Usual Dose of Simvastatin Does Not Inhibit Plaque Progression and Lumen Loss at the Peri-Stent Reference Segments after Bare-Metal Stent Implantation: A Serial Intravascular Ultrasound Analysis
-
Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC
- KMID: 964715
- Korean J Intern Med.
- 2010 Dec;25(4):356-363.
- doi: 10.3904/kjim.2010.25.4.356
BACKGROUND/AIMS: The aim of this study was to assess the effects of a usual dose of simvastatin (20 mg/day) on plaque regression and vascular remodeling at the peri-stent reference segments... -
- CITED
-
- Close
- SHARE
-
- Close
